Show simple item record

dc.contributor.advisorChairperson, Graduate Committee: Blake Wiedenheften
dc.contributor.authorNichols, Joseph Edwarden
dc.contributor.otherThis is a manuscript style paper that includes co-authored chapters.en
dc.date.accessioned2024-02-02T21:43:16Z
dc.date.available2024-02-02T21:43:16Z
dc.date.issued2022en
dc.identifier.urihttps://scholarworks.montana.edu/xmlui/handle/1/18214
dc.description.abstractGenetic modification studies are central to understanding gene function and are the bedrock of molecular biology. The development of novel, CRISPR-based technologies for genome engineering in the last decade has revolutionized nearly every field of biology by simplifying the process of editing DNA genomes. In contrast, there are currently no comparable tools for editing RNA. Our goal is to develop facile CRISPR-based RNA editing methods that will transform our understanding of RNA metabolism, viruses and the repair pathways that govern RNA biology. I didn't initially come to MSU intending to study SARS-CoV-2, but the growing importance of this topic, combined with unanticipated intersections with my interest in CRISPRs, ultimately lead to several projects in this area. While participating in genomic surveillance, we identified a naturally occurring deletion within ORF7a, a viral accessory protein. We determined that this deletion results in the loss of function of ORF7a, limiting the virus' ability to evade host interferon responses, and reduced viral fitness. My focus then moved to Type-III CRISPR systems. While CRISPR has become synonymous with genome engineering, these systems naturally evolved in prokaryotes as an adaptive immune system against bacteriophages. Type-III CRISPR systems are unique, as they are one of two groups of CRISPR systems to target RNA rather than DNA. To develop type III systems for editing RNA, we designed and purified a series of type III complexes and showed that these systems function as programable nucleases. We then adapted a method for targeted RNA repair in vitro following cleavage and demonstrate that this approach results in edited RNA. In addition to cleaving the RNA target, target recognition by type III CRISPR systems also activates a polymerase domain that generates signaling molecules that activate ancillary CRISPR nucleases. Working with several members of the team, I set out to determine substrate preferences for each ancillary nuclease in Thermus thermophilus. We expected that activating these immune components would result in dramatic changes in bacterial growth kinetics. However, my experiments failed to identify a reliable phenotype, suggesting that this expression system is not a faithful representation of Type-III immunity.en
dc.language.isoenen
dc.publisherMontana State University - Bozeman, College of Agricultureen
dc.subject.lcshRNA editingen
dc.subject.lcshCRISPR (Genetics)en
dc.subject.lcshGenetic engineeringen
dc.subject.lcshCOVID-19 (Disease)en
dc.subject.lcshImmunityen
dc.titleMechanisms of RNA-targeting CRISPR systems and their applications for RNA editingen
dc.typeThesisen
dc.rights.holderCopyright 2022 by Joseph Edward Nicholsen
thesis.degree.committeemembersMembers, Graduate Committee: Edward E. Schmidt; Michelle Flennikenen
thesis.degree.departmentMicrobiology & Cell Biology.en
thesis.degree.genreThesisen
thesis.degree.nameMSen
thesis.format.extentfirstpage1en
thesis.format.extentlastpage139en
mus.data.thumbpage27en


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record


MSU uses DSpace software, copyright © 2002-2017  Duraspace. For library collections that are not accessible, we are committed to providing reasonable accommodations and timely access to users with disabilities. For assistance, please submit an accessibility request for library material.